Affinium is a pharmaceutical company focused
on the clinical development of antibacterials.
Our lead development program encompasses
a potent, orally available, novel antibiotic class
for the treatment of antibiotic resistant
For information, please contact:
Owen Roberts, CFA, Chief Financial Officer
Affinium Pharmaceuticals, Inc.
7000 North Mopac Expwy.
Austin, Texas, 78731
1243 Islington Ave.
Toronto, Ontario, M8X 1Y9